NICOLE MOELLER: Open Payments
NPI 1811304140 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,725 in 73 payments from 19 companies in 2025. Trend: 2023 $70 · 2024 $541 · 2025 $1,725
Food & beverage: $1,725
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $337 |
| Exact Sciences Corporation | 6 | $198 |
| Madrigal Pharmaceuticals | 3 | $188 |
| Grifols USA, LLC | 2 | $158 |
| Regeneron Healthcare Solutions, Inc. | 6 | $144 |
| Lilly USA, LLC | 11 | $135 |
| Boston Scientific Corporation | 1 | $120 |
| PFIZER INC. | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
Products named: REZDIFFRA, Ozempic, Prolastin-C Liquid, The Cologuard Plus Collection Kit, DUPIXENT, WATCHMAN, Wegovy, MOUNJARO.
Industry payments across NY — which companies pay providers there.
